Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-743

You were correct


Of course he was .... everyone I have seen you rebut with your long winded posts has been correct ..... I remember in Feb 2023 when you complained for weeks that the company should retract and correct it's ASX announcement as in your opinion it had a typo in Post #:66002392 ?


You were wrong then too .... and of course there was never a retraction from Mesoblast because there was no need for one as they (surprise) were right and knew exactly what they were presented via an ASX announcement .... it's amazing how many times you come on here and claim you are right and everyone else is wrong until suddenly you have to admit you were in fact wrong ... but hey as @reginaldp would say - keep punchin'







Post #:66002392

I think this is a typo -

"Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measured In Vivo Activity based on Mechanism of Action."

I think that should say In Vitro.